Pricing Log in Create free account

Larimar Therapeutics, Inc. (LRMR) vs Q32 Bio Inc. (QTTB)

Larimar Therapeutics, Inc. and Q32 Bio Inc. are both Biotechnology companies. Q32 Bio Inc. is the larger, with a market value of $276.8M against $248.3M — 1.1× the size. Larimar Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 3.1×. Across the 9 metrics below, Q32 Bio Inc. leads on 9 and Larimar Therapeutics, Inc. on 0.

Valuation

Metric LRMR QTTB Biotechnology median
P/E n/m 3.06 10.60
P/S n/m n/m 9.40
P/B 1.95 1.78 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m (13.54) 9.02
Earnings yield (81.59%) 32.65% (32.88%)
Free cash flow yield (62.87%) (6.86%) (23.13%)

Profitability

Metric LRMR QTTB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.41%) 72.14% (51.96%)
Return on assets (108.53%) 37.13% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LRMR QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.76%
EPS growth (last fiscal year) (71.97%) 136.78% 29.88%
Revenue growth, 5-year CAGR — 100.32% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LRMR QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 20.30 4.97
Net debt to EBITDA 0.79 (2.21) 1.01

Dividend

Metric LRMR QTTB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LRMR QTTB Biotechnology median
Market cap 248.28m 276.80m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack